GURUFOCUS.COM » STOCK LIST » Technology » Hardware » Telcon RF Pharmaceutical Inc (XKRX:200230) » Definitions » Capital Expenditure

Telcon RF Pharmaceutical (XKRX:200230) Capital Expenditure : ₩-2,877.24 Mil (TTM As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Telcon RF Pharmaceutical Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Telcon RF Pharmaceutical's cash flow for capital expenditures for the three months ended in Mar. 2024 was ₩-1,552 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-2,877.24 Mil.

Telcon RF Pharmaceutical Capital Expenditure Historical Data

The historical data trend for Telcon RF Pharmaceutical's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Telcon RF Pharmaceutical Capital Expenditure Chart

Telcon RF Pharmaceutical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,079.20 -4,617.05 -5,813.48 -833.96 -1,897.85

Telcon RF Pharmaceutical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -572.26 -668.87 -448.65 -208.07 -1,551.66

Telcon RF Pharmaceutical Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-2,877.24 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Telcon RF Pharmaceutical (XKRX:200230) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Technology » Hardware » Telcon RF Pharmaceutical Inc (XKRX:200230) » Definitions » Capital Expenditure
Comparable Companies
XKRX:069540 XKRX:031820 XKRX:038680 XKRX:015710 XKRX:115440 XKRX:000300 XKRX:100590 XKRX:046970 XKRX:332570 XKRX:388790 CSCO MSI SHSE:601138 HPE OHEL:NOKIA SZSE:000063 SHSE:688036 OSTO:ERIC B ZBRA TPE:2345
Traded in Other Exchanges
N/A
Address
684, Dongtangiheung-ro, Giheung-gu, Gyeonggi-do, Yongin-si, KOR, 17102
Website
http://www.telcon.co.kr
Telcon RF Pharmaceutical Inc manufactures wireless communication equipment. It is engaged in developing connectors for input and output port, board to board, cable assembly, and board to mount used in wireless communication equipment. The company also supply's RF coaxial connectors.

Telcon RF Pharmaceutical (XKRX:200230) Headlines

No Headlines